Dear user,

ET HealthWorld privacy and cookie policy has been updated to align with the new data regulations in European Union. Please review and accept these changes below to continue using the website.

You can see our privacy policy & our cookie policy. We use cookies to ensure the best experience for you on our website.

If you choose to ignore this message, we’ll assume that you are happy to receive all cookies on ET HealthWorld.
EU to discuss coordinated response to China COVID situation on Wed
Passengers taking transit flights to India from high risk countries also need a negative RT-PCR report to fill Air Suvidha form: Govt




25 February, 2022
25 February, 2022
25 November, 2022
1 Octuber, 2021

Rebooting Cancer Awareness
The unsung hero in faster holistic recovery
Technological Disruption in Indian Health & Pharma
Do you think you are up for the challenge?
Holistic Solutions For A Healthier India






Adopting-Dynamic-Technologies


According to the Indian Council of Medical Research (ICMR), 25.3 per cent of young individuals with diabetes under the age of 25 have type – 2 diabetes. Diabetes is affecting young people in their most productive years. Youth with T2D tend to have higher rates of complications, more aggressive disease, with more rapid loss of beta-cell function and a less favourable response to treatment than adults. If it is not diagnosed and managed properly at an early stage, it may increase the risk of developing chronic diseases and severely affect the life expectancy of future generations.
Get exclusive Industry Insights and Analysis through our “Exclusive” Stories brought to you by our award-winning journalists
By continuing, you agree to the Terms & Conditions and acknowledge our Privacy Policy. This same account can be used across all Economic Times B2B portals.
Recommended by ColombiaColumbia
125000+ Industry Leaders read it everyday
India has confirmed its first case of Omicron’s XBB.1.5 in Gujarat this December, Insacog data showed.
Nepal’s Department of Drug Administration has published a list of 16 Indian pharmaceutical companies, including Divya Pharmacy that manufactures Yoga guru Ramdev’s Patanjali products, that failed to comply with the World Health Organization’s (WHO) good manufacturing practices.
We have various options to advertise with us including Events, Advertorials, Banners, Mailers, Webinars etc.
Please contact us to know more details.
Get ETHealthworld‘s top stories every morning in your email inbox.
125000+ Industry Leaders read it everyday
Follow @ETHealthworld for the latest news, insider access to events and more.

source

By admin

Leave a Reply

Your email address will not be published. Required fields are marked *